TSS
BEAM icon

Two Sigma Securities’s Beam Therapeutics BEAM Stock Holding History

Two Sigma Securities’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$470K Buy
13,700
+3,470
+34% +$105K 0.04% 621
2026
Q1 		$244K Buy
+10,230
New +$284K 0.03% 927

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Two Sigma Securities's BEAM Position: Q2 2026 in Review

Two Sigma Securities increased its Beam Therapeutics (BEAM) stake by 34% in Q2 2026, buying an estimated $105K and bringing the position to 13,700 shares worth $470K. The position accounts for 0.04% of the portfolio, ranked #621.

Two Sigma Securities first reported a position in BEAM in Q1 2026 and has held it in 2 quarters since. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Two Sigma Securities held 13,700 shares of Beam Therapeutics worth $470K as of Q2 2026.
  • Two Sigma Securities bought 3,470 Beam Therapeutics shares in Q2 2026, an estimated $105K.
  • Beam Therapeutics made up 0.04% of Two Sigma Securities's portfolio in Q2 2026, its #621 holding.
  • Two Sigma Securities first reported a position in Beam Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.